This previous study implied that the infiltration of CD68+ TAMs wasn’t associated with recurrence and mortality of CRC, which may be attributed to the functional counterbalance modulated by the M1 and M2 TAMs (35). The gene discussed is CD68; the disease is colorectal carcinoma.